ProSciento, Inc.

We share the Obesity Action Coalition’s dedication to advancing better treatments for obesity and other metabolic conditions such as type 1 & type 2 diabetes and steatotic liver disease. Together, we are committed to raising awareness, fostering obesity research, and advocating for those affected by these conditions.   By uniting individuals, families, healthcare professionals, pharmaceuticals, and organizations, we can make a difference in the lives of millions.   #ObesityActionCoalition #ObesityAwareness #ClinicalResearch #PatientAdvocacy #MetabolicHealth #MetabolicDiseases #Type1Diabetes #Type2Diabetes #SteatoticLiverDisease #MetabolicContinuum #ScienceDriven #PatientFocused

Partner with ProSciento, the leading clinical research provider for type 1 and type 2 diabetes, pioneering therapies and devices that significantly enhance patient care. We’re excited to see you at the European Association for the Study of Diabetes e.V. (EASD) 2024! Visit booth E13 or schedule a meeting: https://bit.ly/4ce71W6 #EASD2024 #MetabolicDiseases #ClinicalTrials #DiabetesResearch #DiabetesCRO #Type1Diabetes #Type2Diabetes #MetabolicContinuum #ScienceDriven #PatientFocused

ProSciento is proud to support the American Diabetes Association Southern California Step Out Walk to Stop Diabetes for the 20th year! We are honored to be a sponsor and appreciate the ADA for organizing this crucial event, fostering unity and a shared purpose in the fight to end diabetes. Join us in this important cause: https://bit.ly/4fAmIcV. #StopDiabetes #ADAStepOut #WeFightDiabetes #DiabetesResearch #Type1Diabetes #Type2Diabetes #CommunityUnity #ScienceDriven #PatientFocused

Join us at the European Association for the Study of Diabetes e.V. (EASD)! Don't miss the chance to connect with our scientific and business development teams, who are dedicated to advancing diseases across the metabolic continuum, with unparalleled expertise in #Diabetes, #Obesity, and #SteatoticLiverDisease. Schedule your meeting today at https://bit.ly/4ce71W6 and be sure to visit us at booth E13. See you there! #EASD2024 #MetabolicDiseases #ClinicalTrials #DiabetesResearch #DiabetesCRO #Type1Diabetes #Type2Diabetes #MetabolicContinuum #ScienceDriven #PatientFocused

Partnering with a CRO focused on diseases across the #MetabolicContinuum is critical when you have an obesity-related program. Our data-driven recruitment ensures enrollment of eligible patients at highly qualified sites for obesity trials, boosting engagement and retention. With a global network and advanced technologies, we streamline operations and enhance efficiency. Partner with us to advance #ObesityResearch: https://bit.ly/3zICIq3 #ScienceDriven #PatientFocused

For 20+ years, our science-driven team is renowned for unparalleled expertise in supporting research for diseases across the #MetabolicContinuum. Patients are at the heart of our mission. By tailoring treatments to the specific characteristics of each patient’s metabolic condition, we aim to improve symptom management, enhance quality of life, and reduce side effects. Our patient-centered approach is driving a new era of collaborative research and therapeutic interventions. Join us in advancing metabolic disease clinical research and discovering new preventive strategies. Together, we can make a difference! Learn more: https://bit.ly/3zxqDXr #Obesity #Diabetes #LiverDisease #ScienceDriven #PatientFocused

Happy #IndependenceDay! We celebrate the spirit of independence, freedom, and unity that defines our great nation. As we enjoy the festivities with family and friends, let’s also remember the values that bring us together. Wishing everyone a safe and joyful #4thOfJuly! #CelebrateFreedom #MetabolicContinuum #ScienceDriven #PatientFocused

Missed us at #ADA2024? No worries, schedule a meeting today to meet with the specialized experts to accelerate #diabetes drug and device development. Join us in advancing #diabetes research and optimizing patient outcomes. Together, we can make a difference! https://bit.ly/4bZVPgw #ADA2024 #ADAScientificSessions #DiabetesResearch #Type1Diabetes #Type2Diabetes #MetabolicContinuum #ScienceDriven #PatientFocused

Today’s the last day at the American Diabetes Association’s 84th Scientific Sessions! For over 20 years, ProSciento has been at the forefront of supporting clinical research for the continuum of metabolic diseases. Learn how our specialized expertise in the design and conduct of clinical trials for #diabetes can provide a competitive advantage for your therapeutic or device programs. Visit us at booth 1229 or schedule a meeting: https://bit.ly/44MUlDu. #ADA2024 #MetabolicDiseases #ScientificResearch #ADA2024 #ADAScientificSessions #DiabetesResearch #Type1Diabetes #Type2Diabetes #MetabolicContinuum #ScienceDriven #PatientFocused

Excited to be at the American Diabetes Association’s 84th Scientific Sessions! ProSciento is dedicated to enhancing patient access and engagement for clinical research focused on diseases across the metabolic continuum. Meet with the CRO that has conducted more early phase type 1 and type 2 #diabetes clinical studies than any other U.S. provider. Visit us at booth 1229 or schedule a meeting: https://lnkd.in/g4fcbSgU. #ADA2024 #ADAScientificSessions #DiabetesResearch #Type1Diabetes #Type2Diabetes #MetabolicContinuum #ScienceDriven #PatientFocused Stephanie Vetere Camilyn Larsen Maria Nunez Alejandra Macias Pulido, MD